Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Gene Modulation of NLRP3, IL-1β and TNF-α in Peripheral Blood of Patients With Exogenous Obesity Treated With Berberine

NCT06703086 is registered in ClinicalTrials.gov with National Polytechnic Institute, Mexico as lead sponsor.

NCT NCT06703086
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06703086 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Gene Modulation of NLRP3, IL-1β and TNF-α in Peripheral Blood of Patients With Exogenous Obesity Treated With Berberine
Lead sponsor
National Polytechnic Institute, Mexico
Phase
Not applicable
Overall status
Completed
Start date
January 5, 2019
Completion date
February 15, 2020
Enrollment
120 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

berberine, obesity, overweight